[HTML][HTML] Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
D Lapuente, J Fuchs, J Willar, A Vieira Antão… - Nature …, 2021 - nature.com
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are
needed to maintain or increase immunity due to waning responses and the emergence of …
needed to maintain or increase immunity due to waning responses and the emergence of …
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
D Lapuente, J Fuchs, J Willar… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are
needed to maintain or increase immunity due to waning responses and the emergence of …
needed to maintain or increase immunity due to waning responses and the emergence of …
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization
D Lapuente, J Fuchs, J Willar, AV Antao, V Everlein… - 2021 - pesquisa.bvsalud.org
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal
adenoviral vector immunization | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Protective …
adenoviral vector immunization | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Protective …
[PDF][PDF] Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal
D Lapuente, J Fuchs, J Willar, AV Antão, V Eberlein… - researchgate.net
Several effective SARS-CoV-2 vaccines are currently in use, but in the light of waning
immunity and the 25 emergence of novel variants, effective boost modalities are needed in …
immunity and the 25 emergence of novel variants, effective boost modalities are needed in …
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization
D Lapuente, J Fuchs, J Willar, AV Antão, V Eberlein… - bioRxiv, 2021 - biorxiv.org
Several effective SARS-CoV-2 vaccines are currently in use, but in the light of waning
immunity and the emergence of novel variants, effective boost modalities are needed in …
immunity and the emergence of novel variants, effective boost modalities are needed in …
[HTML][HTML] Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
D Lapuente, J Fuchs, J Willar, AV Antão… - Nature …, 2021 - ncbi.nlm.nih.gov
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are
needed to maintain or increase immunity due to waning responses and the emergence of …
needed to maintain or increase immunity due to waning responses and the emergence of …
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
D Lapuente, J Fuchs, J Willar, AV Antão, V Eberlein… - 2021 - publica.fraunhofer.de
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are
needed to maintain or increase immunity due to waning responses and the emergence of …
needed to maintain or increase immunity due to waning responses and the emergence of …
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.
D Lapuente, J Fuchs, J Willar, V Eberlein… - Nature …, 2021 - europepmc.org
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are
needed to maintain or increase immunity due to waning responses and the emergence of …
needed to maintain or increase immunity due to waning responses and the emergence of …
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
D Lapuente, J Fuchs, J Willar, AV Antão… - Nature …, 2021 - econpapers.repec.org
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are
needed to maintain or increase immunity due to waning responses and the emergence of …
needed to maintain or increase immunity due to waning responses and the emergence of …
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.
D Lapuente, J Fuchs, J Willar… - Nature …, 2021 - search.ebscohost.com
Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are
needed to maintain or increase immunity due to waning responses and the emergence of …
needed to maintain or increase immunity due to waning responses and the emergence of …